Fundz

Bectas Therapeutics reported raising $4.15 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEOct 09, 2024Late filing, first sale Oct 21, 2022$4.2M of $10M raised

Amount Raised

$4.15 Million

$4.15 Million sold, per SEC Form D (first sale Oct 21, 2022)

Round Type

Seed

HoustonBiotechnology

Quick answer

Bectas Therapeutics raised $4.15 Million in a Seed round, dated October 21, 2022. Bectas Therapeutics is based in Houston, Texas, United States.

How much did Bectas Therapeutics raise?
Bectas Therapeutics raised $4.15 Million in a Seed round on October 21, 2022.
What does Bectas Therapeutics do?
Bectas Therapeutics is a preclinical-stage biotech company developing monoclonal antibody therapies for cancer accompanied by biomarkers to identify patients that will most benefit from each Bectas therapeutic antibody.
Where is Bectas Therapeutics based and how big is it?
Bectas Therapeutics is based in Houston, Texas, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Bectas Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Aqualung Therapeutics Corp. raised $1.5M (Series A) on December 5, 2022.
  • Rejoni raised $26M on December 5, 2022.
  • Bactobio raised $7.8M (Funding Round) on December 5, 2022.
  • Vaxxas raised $23M (Funding Round) on December 5, 2022.
  • Advicenne raised an undisclosed amount (Debt Financing) on December 5, 2022.
  • ABK Biomedical raised $28M on December 5, 2022.

Who to call at Bectas Therapeutics, and when

A new round usually means Bectas Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bectas Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bectas Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bectas Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bectas Therapeutics

Location

3262 WESTHEIMER ROAD

Houston, Texas, United States

About

Bectas Therapeutics is a preclinical-stage biotech company developing monoclonal antibody therapies for cancer accompanied by biomarkers to identify patients that will most benefit from each Bectas therapeutic antibody. Our programs combine monoclonal antibodies that exhibit best-in-class pre-clinical activity with precision insights that enable first-in-class therapies to serve patients across multiple cancer indications

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bectas Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bectas Therapeutics's next move

See what Strategic adds

Bectas Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.